| Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. | None |
| The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | None |
| Functionality of clonal lymphoid progenitor cells expressing the P210 BCR/ABL oncogene. | None |
| Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells. | None |
| Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line. | None |
| Transposition of the abl proto-oncogene in Philadelphia--negative chronic myeloid leukaemia and acute lymphocytic leukaemia. | None |
| Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation. | None |
| Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog. | None |
| Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL. | None |
| Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis. | None |
| Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs. | None |
| Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor alpha and bcr-abl oncogene addiction in malignant hematologic cells. | None |
| TAT-CC fusion protein depresses the oncogenicity of BCR-ABL through interrupting its oligomerization. | None |
| Transcriptional suppression of BACH2 by the Bcr-Abl oncoprotein is mediated by PAX5. | None |
| The tyrosine phosphatase TC48 interacts with and inactivates the oncogenic fusion protein BCR-Abl but not cellular Abl. | None |
| Breakpoint cluster region-c-abl oncogene 1, non-receptor tyrosine kinase signaling: current patterns of the versatile regulator revisited. | None |
| our results identify eIF4B as a critical substrate of Pim kinases in mediating the activity of Abl oncogenes | None |
| Chromosomal mapping of the murine c-abl proto-oncogene by in situ hybridization. | None |
| Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. | None |
| Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein. | None |